drugset / Trial / NCT02646124

Diazepam Use With Standard Management for Acute Low Back Pain

NCT02646124

Phase 2/3 Completed 114 enrolled Montefiore Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

Given the poor pain and functional outcomes that persist beyond an Emergency Department (ED) visit for musculoskeletal low back pain (LBP), we propose a clinical trial to evaluate whether combining a benzodiazepine with an NSAID is more effective than nonsteroidal antiinflammatory drug (NSAID) monotherapy for the treatment of acute, non-traumatic, non-radicular low back pain.

Timeline

Start
2015-06
Primary completion
2016-02
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule 5 mg Oral
Background Naproxen Small molecule 500 mg Oral

Indications

No indication recorded.